Precision Medicine for aTTP: Expert Answers to Your Questions
In this podcast episode, listen to Ara Metjian, MD; Paul Coppo, MD, PhD; and Marshall Mazepa, MD, answer questions from an audience of healthcare professionals on precision medicine and new guidelines for aTTP.
Decera Clinical Education Oncology Podcast · Ara Metjian MD, Marshall Mazepa MD, Paul Coppo MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Ara Metjian, MD; Paul Coppo, MD, PhD; and Marshal Mazepa, MD, answer questions from an audience of healthcare professionals on topics related to the management of acquired thrombotic thrombocytopenic purpura (aTTP), including:
- Rationale of the CAPLAVIE regimen of caplacizumab with corticosteroids and rituximab in aTTP in the acute phase
- Data for caplacizumab in pediatric patients with aTTP
- Initiating rituximab after completion of plasma exchange
- International Society on Thrombosis and Haemostasis guideline recommendations against using aspirin
- Triggers of aTTP episodes aside from infection
- Effect of COVID-19 vaccines and COVID-19 infections on aTTP onset or relapse
Presenters:
Ara Metjian, MD
Associate Professor
Division of Hematology
Department of Medicine
University of Colorado, Anschutz Medical Campus
Aurora, Colorado
Paul Coppo, MD, PhD
Professor of Hematology
Hematology Department, AP-HP
Sorbonne University
Paris, France
Marshall Mazepa, MD
Assistant Professor of Medicine
Division of Hematology, Oncology, and Transplantation
University of Minnesota
Minneapolis, Minnesota
Link to the complete program, including downloadable slidesets, an expert commentary, an on-demand webcast, and healthcare professional resource guide:
https://bit.ly/3J1fcad
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.